Abstract
Human Papillomavirus type 16 (HPV 16) DNA is regularly found in around 50% of all cervical carcinomas. Variants of this type have been found associated with different risks for cervical cancer development. Presence of HPV 16 variants in Colombia has not been previously reported. The aims of this study were to assess the feasibility of non-radioactive PCR-SSCP (polymerase chain reaction single-strand conformation polymorphism) analysis for determination of variability of ORF of E6, variability in the enhancer sequence of the LCR, and for establishment of the distribution of HPV 16 variants in invasive squamous cell carcinoma of the uterine cervix in Colombian women. Biopsies from 59 patients at the Instituto Nacional de Cancerología (INC) in Bogotá (Colombia) were collected. HPV detection was performed using universal primers. HPV 16 variants were detected by non-radioactive single-stranded conformational polymorphism (SSCP) analysis and direct sequencing. HPV 16 was detected in 57.6% of the tumors. The European branch was identified in 88.2% of the samples with the E-G350 class being the most prevalent variant (41.1%). The Asian-American branch was identified in 8.8% of the samples. Within this group it was possible to distinguish between c and a classes. It was not possible to determine the branch in 2.9% of the cases. A nucleotide transition (G to A) at position 7521 was the most prevalent variation (80%) found in the enhancer sequence of the LCR region. Conclusion: A non-radioactive PCR-SSCP analysis allowed us to distinguish between European and Asian-American branches of HPV 16, and to distinguish among classes in squamous cell carcinomas of the uterine cervix in Colombia. This method is an excellent alternative that can be used as a screening tool for identification of HPV 16 variants.
Similar content being viewed by others
References
D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Int. J. Cancer 94, 153–156 (2001). doi:https://doi.org/10.1002/ijc.1440
M. Piñeros, J. Ferlay, R. Murillo, Instituto Nacional de Cancerología, Imprenta Nacional (2005)
J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, N. Munoz, J. Pathol. 189, 12–19 (1999). doi:https://doi.org/10.1002/(SICI) 1096-9896(199909) 189:1≤12::AID-PATH431≥3.0.CO;2-F
G.M. Clifford, M.A. Goncalves, S. Franceschi, AIDS 20, 2337–2344 (2006). doi:https://doi.org/10.1097/01.aids.0000253361.63578.14
N. Munoz, F. Mendez, H. Posso, M. Molano, A.J. van den Brule, M. Ronderos, C. Meijer, A. Munoz, J. Infect. Dis. 190, 2077–2087 (2004). doi:https://doi.org/10.1086/425907
F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, K.V. Shah, J. Natl. Cancer Inst. 87, 796–802 (1995). doi:https://doi.org/10.1093/jnci/87.11.796
N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer, N. Engl. J. Med. 348, 518–527 (2003). doi:https://doi.org/10.1056/NEJMoa021641
H.U. Bernard, I.E. Calleja-Macias, S.T. Dunn, Int. J. Cancer. 118, 1071–1076 (2006). doi:https://doi.org/10.1002/ijc.21655
H.U. Bernard, J. Clin. Virol. 32(Suppl 1), S1–S6 (2005). doi:https://doi.org/10.1016/j.jcv.2004.10.021
L. Ho, S.Y. Chan, R.D. Burk, B.C. Das, K. Fujinaga, J.P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos, J. Virol. 67, 6413–6423 (1993)
T. Yamada, M.M. Manos, J. Peto, C.E. Greer, N. Munoz, F.X. Bosch, C.M. Wheeler, J. Virol. 71, 2463–2472 (1997)
Z. Chen, M. Terai, L. Fu, R. Herrero, R. DeSalle, R.D. Burk, J. Virol. 79, 7014–7023 (2005). doi:https://doi.org/10.1128/JVI.79.11.7014-7023.2005
L. Sichero, H. Trottier, S. Ferreira, E. Duarte-Franco, E.L. Franco, L.L. Villa, J. Natl. Cancer. Inst. 99, 653–654 (2007). doi:https://doi.org/10.1093/jnci/djk136
L. Sichero, S. Ferreira, H. Trottier, E. Duarte-Franco, A. Ferenczy, E.L. Franco, L.L. Villa, Int. J. Cancer. 120, 1763–1768 (2007). doi:https://doi.org/10.1002/ijc.22481
M. Grodzki, G. Besson, C. Clavel, A. Arslan, S. Franceshi, P. Birembaut, M. Tommasino, I. Zehbe, Cancer Epidemiol. Biomarkers Prev. 15, 820–822 (2006). doi:https://doi.org/10.1158/1055-9965.EPI-05-0864
J. Berumen, R.M. Ordonez, E. Lazcano, J. Salmeron, S.C. Galvan, R.A. Estrada, E. Yunes, A. Garcia-Carranca, G. Gonzalez-Lira, A. Madrigal-de la Campa, J. Natl. Cancer Inst. 93, 1325–1330 (2001). doi:https://doi.org/10.1093/jnci/93.17.1325
I. Nindl, K. Rindfleisch, B. Lotz, A. Schneider, M. Durst, Int. J. Cancer 82, 203–207 (1999). doi:https://doi.org/10.1002/(SICI) 1097-0215(19990719) 82:2≤203::AID-IJC9≥3.0.CO;2-9
M. Refugio Gonzalez-Losa, M. Laviada, M. Puerto-Solis, A. Garcia-Carranca, J. Clin. Virol. 29, 95–98 (2004). doi:https://doi.org/10.1016/S1386-6532(03) 00094-5
I. Zehbe, J. Mytilineos, I. Wikstrom, R. Henriksen, L. Edler, M. Tommasino, Hum. Immunol. 64, 538–542 (2003). doi:https://doi.org/10.1016/S0198-8859(03) 00033-8
C. Kammer, M. Tommasino, S. Syrjanen, H. Delius, U. Hebling, U. Warthorst, H. Pfister, I. Zehbe, Br. J. Cancer 86, 269–273 (2002). doi:https://doi.org/10.1038/sj.bjc.6600024
M.J. O’Connor, W. Stunkel, H. Zimmermann, C.H. Koh, H.U. Bernard, J. Virol. 72, 10083–10092 (1998)
G. Veress, K. Szarka, X.P. Dong, L. Gergely, H. Pfister, J. Gen. Virol. 80, 1035–1043 (1999)
T. Chong, W.K. Chan, H.U. Bernard, Nucleic Acids Res. 18, 465–470 (1990). doi:https://doi.org/10.1093/nar/18.3.465
X.P. Dong, F. Stubenrauch, E. Beyer-Finkler, H. Pfister, Int. J. Cancer 58, 803–808 (1994). doi:https://doi.org/10.1002/ijc.2910580609
K. Kurvinen, M. Yliskoski, S. Saarikoski, K. Syrjanen, S. Syrjanen, Eur. J. Cancer 36, 1402–1410 (2000). doi:https://doi.org/10.1016/S0959-8049(00) 00121-0
J.R. Ellis, P.J. Keating, J. Baird, E.F. Hounsell, D.V. Renouf, M. Rowe, D. Hopkins, M.F. Duggan-Keen, J.S. Bartholomew, L.S. Young, Nat. Med. 1, 464–470 (1995). doi:https://doi.org/10.1038/nm0595-464
S. Andersson, M. Alemi, E. Rylander, A. Strand, B. Larsson, J. Sallstrom, E. Wilander, Br. J. Cancer 83, 307–310 (2000). doi:https://doi.org/10.1054/bjoc.2000.1247
O. Chakrabarti, K. Veeraraghavalu, V. Tergaonkar, Y. Liu, E.J. Androphy, M.A. Stanley, S. Krishna, J. Virol. 78, 5934–5945 (2004). doi:https://doi.org/10.1128/JVI.78.11.5934-5945.2004
A. Giannoudis, C.S. Herrington, J. Pathol. 193, 295–302 (2001). doi:https://doi.org/10.1002/1096-9896(2000) 9999:9999≤::AID-PATH809≥3.0.CO;2-C
P. Londesborough, L. Ho, G. Terry, J. Cuzick, C. Wheeler, A. Singer, Int. J. Cancer 69, 364–368 (1996). doi:https://doi.org/10.1002/(SICI) 1097-0215(19961021) 69:5≤364::AID-IJC2≥3.0.CO;2-3
I. Zehbe, G. Voglino, H. Delius, E. Wilander, M. Tommasino, Lancet 352, 1441–1442 (1998). doi:https://doi.org/10.1016/S0140-6736(05) 61263-9
M. Grodzki, G. Besson, C. Clavel, A. Arslan, S. Franceschi, P. Birembaut, M. Tommasino, I. Zehbe, Cancer Epidemiol. Biomarkers Prev. 15, 820–822 (2006). doi:https://doi.org/10.1158/1055-9965.EPI-05-0864
R.K. Saiki, D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, H.A. Erlich, Science 239, 487–491 (1988). doi:https://doi.org/10.1126/science.2448875
A.M. Roda Husman, J.M. Walboomers, A.J. van den Brule, C.J. Meijer, P.J. Snijders, J. Gen. Virol. 76, 1057–1062 (1995)
M. Schmidt, W. Kedzia, A. Gozdzicka-Jozefiak, J. Clin. Virol. 23, 65–77 (2001). doi:https://doi.org/10.1016/S1386-6532(01) 00189-5
M. Alemi, S. Andersson, J. Sallstrom, E. Wilander, Diagn. Mol. Pathol. 8, 97–100 (1999). doi:https://doi.org/10.1097/00019606-199906000-00006
K. Hayashi, D.W. Yandell, Hum. Mutat. 2, 338–346 (1993). doi:https://doi.org/10.1002/humu.1380020503
I. Zehbe, J.F. Sallstrom, M. Evander, K. Edlund, E. Rylander, G. Wadell, E. Wilander, Diagn. Mol. Pathol. 5, 206–213 (1996). doi:https://doi.org/10.1097/00019606-199609000-00010
J.D. Meissner, J. Gen. Virol. 80, 1725–1733 (1999)
G. Myers, H.U. Bernard, H. Delius, M. Favre, J. Icenogle, M. Van Rast, C. Wheeler (eds.), Human Papillomaviruses 1996: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Los Alamos National Laboratory, Los Alamos, NM, USA, 1996)
T. Yamada, C.M. Wheeler, A.L. Halpern, A.C. Stewart, A. Hildesheim, S.A. Jenison, J. Virol. 69, 7743–7753 (1995)
H. Lichtig, M. Algrisi, L.E. Botzer, T. Abadi, Y. Verbitzky, A. Jackman, M. Tommasino, I. Zehbe, L. Sherman, Virology 350, 216–227 (2006). doi:https://doi.org/10.1016/j.virol.2006.01.038
J.S. Park, E.S. Hwang, C.J. Lee, C.J. Kim, J.G. Rha, S.J. Kim, S.E. Namkoong, S.J. Um, Gynecol. Oncol. 74, 23–29 (1999). doi:https://doi.org/10.1006/gyno.1999.5399
T.R. Alencar, D.M. Cerqueira, M.R. da Cruz, P.S. Wyant, E.D. Ramalho, C.R. Martins, Vírus Genes 35, 1–4 (2007). doi:https://doi.org/10.1007/s11262-006-0040-5
M. O’Connor, S.Y. Chan, H.U. Bernard, in Human Papillomaviruses 1995 Compendium, ed. by G. Myers, H.U. Bernard, H. Delius, C. Baker, J. Icenogle, A. Halpern, C. Wheeler (Los Alamos National Laboratory, Los Alamos, NM, USA, 1995), pp. 21–40
M.J. O’Connor, S.H. Tan, C.H. Tan, H.U. Bernard, J. Virol. 70, 6529–6539 (1996)
Acknowledgments
We thank Bernardo Avellaneda for his help in the preparation of section biopsies. We also acknowledge to Marcela Lizano for critical reading of the manuscript. This work received financial support from the Instituto Nacional de Cancerología (Colombia) through the investment project “Use of Cold Probes in the Study of the Relation between HPV and Cancer of the Uterine Cervix” (Code 4103038-1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreno-Acosta, P., Molano, M., Huertas, A. et al. A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia. Virus Genes 37, 22–30 (2008). https://doi.org/10.1007/s11262-008-0239-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-008-0239-8